Catalyst Pharmaceutical CPRX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's other income, net (note 6)?
- Catalyst Pharmaceutical (CPRX) reported other income, net (note 6) of $11M in Q1 2026.
- How has Catalyst Pharmaceutical's other income, net (note 6) changed year-over-year?
- Catalyst Pharmaceutical's other income, net (note 6) increased by 38.9% year-over-year, from $7.92M to $11M.
- What is the long-term trend for Catalyst Pharmaceutical's other income, net (note 6)?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's other income, net (note 6) has grown at a 209.1% compound annual growth rate (CAGR), from $282K to $25.74M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.